Huakang Biomedical Files Director List to HKEX
Huakang Biomedical Holdings Co. Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board comprises Executive Directors Ms. Zhang Yujing (Co-Chairman), Dr. Zhou Xunyong (Co-Chairman), Mr. Zhang Chunguang, and Mr. Poon Lai Yin Michael (Compliance Officer); Non-executive Directors Dr. Bu Su and Dr. Xu Ming; and Independent Non-executive Directors Dr. Chow Kwok Fai Joseph, Ms. Wang Yachun, and Mr. Tsui Wing Tak. Committee memberships were also disclosed: Mr. Tsui Wing Tak chairs the Audit Committee, with Dr. Chow Kwok Fai Joseph and Ms. Wang Yachun as members. Ms. Wang Yachun chairs the Remuneration Committee, joined by Mr. Zhang Chunguang and Dr. Chow Kwok Fai Joseph as members. Ms. Zhang Yujing leads the Nomination Committee, with Dr. Chow Kwok Fai Joseph, Ms. Wang Yachun, and Mr. Tsui Wing Tak serving as members.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Huakang Biomedical Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11953072), on December 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.